DiviDrip · CNTX

CNTX — Context Therapeutics Inc. Common Stock

CNTX is Context Therapeutics Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $0.36. Market cap: $33M. Capital Quality Rank: 12/100 — Capital destroyer.

Stock snapshot

Price$0.36
Market cap$33M
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)12 / 100 · Capital destroyer
Shareholder buyback yield-30.00%
Altman Z-score zoneGrey

About CNTX

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Listed2021Employees15HQPhiladelphia, PASectorHealthcareWebsitecontexttherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside CNTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is CNTX's current stock price?

CNTX (Context Therapeutics Inc. Common Stock) is currently trading at $0.36.

Does CNTX pay a dividend?

CNTX (Context Therapeutics Inc. Common Stock) does not currently pay a regular dividend.

What is CNTX's Capital Quality Rank?

CNTX has a Capital Quality Rank of 12/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track CNTX in DiviDrip

Add CNTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow